Statement Of Financial Position [Abstract]

Sopharma Trading AD - Filing #6022492

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
105,805,000.000 BGN
113,706,000.000 BGN
Investment property
27,000.000 BGN
27,000.000 BGN
Non-current assets or disposal groups classified as held for sale or as held for distribution to owners
77,000.000 BGN
- BGN
Deferred tax assets
850,000.000 BGN
802,000.000 BGN
Cash and cash equivalents
11,694,000.000 BGN
7,275,000.000 BGN
Assets
582,859,000.000 BGN
616,529,000.000 BGN
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
34,276,000.000 BGN
34,276,000.000 BGN
Retained earnings
25,773,000.000 BGN
10,723,000.000 BGN
Equity
24,912,000.000 BGN
25,773,000.000 BGN
225,000.000 BGN
50,463,000.000 BGN
84,900,000.000 BGN
797,000.000 BGN
34,276,000.000 BGN
789,000.000 BGN
34,276,000.000 BGN
76,938,000.000 BGN
10,723,000.000 BGN
29,609,000.000 BGN
22,595,000.000 BGN
392,000.000 BGN
76,938,000.000 BGN
34,276,000.000 BGN
2,038,000.000 BGN
21,806,000.000 BGN
75,804,000.000 BGN
20,585,000.000 BGN
395,000.000 BGN
780,000.000 BGN
Liabilities [abstract]
Deferred tax liabilities
2,093,000.000 BGN
3,230,000.000 BGN
Liabilities
497,959,000.000 BGN
539,591,000.000 BGN
Equity and liabilities
582,859,000.000 BGN
616,529,000.000 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.